Deep Vein Thrombosis and Pulmonary Embolism as a Complication of Traditional Chinese Acupuncture and Cupping

We provide the first reported case of deep vein thrombosis with pulmonary embolism following acupuncture and cupping. This is a reminder that although serious adverse events associated with acupuncture and cupping are reportedly rare when performed by qualified practitioners, life-threatening complications can still arise.

Download Full-text

Necrotizing Fasciitis in a Plaster-Casted Limb: Case Report

American Journal of Critical Care ◽

10.4037/ajcc2009363 ◽

2009 ◽

Vol 18 (3) ◽

pp. 288-287 ◽

Cited By ~ 6

Author(s):

Giora Netzer ◽

Barry D. Fuchs

Keyword(s):

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Case Report ◽

Early Diagnosis ◽

Necrotizing Fasciitis ◽

Tibial Fracture ◽

Suspected Infection ◽

Vein Thrombosis ◽

Life Threatening ◽

Deep Vein

Casts may be associated with, and mask, serious life-threatening complications, including infection, compartment syndrome, and deep vein thrombosis with or without pulmonary embolism. A 43-year-old woman had necrotizing fasciitis associated with a closed-reduction casting of a tibial fracture. Her treatment highlights the importance of removing a cast and assessing the skin and tissue underneath for signs of infection in patients with suspected infection. Thorough assessment, early diagnosis, and early intervention in necrotizing fasciitis and sepsis are important to improve patients’ outcomes.

Download Full-text

Short- and long-term outcomes for the surgical treatment of acute pulmonary embolism

Innovative Surgical Sciences ◽

10.1515/iss-2018-0024 ◽

2018 ◽

Vol 3 (4) ◽

pp. 271-276 ◽

Cited By ~ 1

Author(s):

Kathrin Dohle ◽

Daniel-Sebastian Dohle ◽

Hazem El Beyrouti ◽

Katja Buschmann ◽

Anna Lena Emrich ◽

...

Keyword(s):

Risk Factors ◽

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Hospital Mortality ◽

Acute Pulmonary Embolism ◽

Pulmonary Embolectomy ◽

Vein Thrombosis ◽

Life Threatening ◽

Deep Vein

AbstractObjectivesAcute pulmonary embolism can be a life-threatening condition with a high mortality. The treatment choice is a matter of debate. The early and late outcomes of patients treated with surgical pulmonary embolectomy for acute pulmonary embolism in a single center were analyzed.MethodsAll consecutive patients operated on for pulmonary embolism between January 2002 and March 2017 were reviewed. Patient demographics and pre- and postoperative clinical data were retrieved from our patient registry, and risk factors for in-hospital and long-term mortality were identified.ResultsIn total, 175 patients (mean age 59±3 years, 50% male) were operated on for acute pulmonary embolism. In-hospital mortality was 19% (34/175). No differences were found when comparing surgery utilizing a beating heart or cardioplegic arrest. Risk factors for in-hospital mortality were age >70 years [odds ratio (OR) 4.8, confidence interval (CI) 1.7–13.1, p=0.002], body surface area <2 m2 (OR 4.7, CI 1.6–13.7, p=0.004), preoperative resuscitation (OR 14.1, CI 4.9–40.8, p<0.001), and the absence of deep vein thrombosis (OR 9.6, CI 2.5–37.6, p<0.001). Follow-up was 100% complete with a 10-year survival rate of 66.4% in 141/175 patients surviving to discharge. Once discharged from hospital, none of the risk factors identified for in-hospital mortality were relevant for long-term survival except the absence of deep vein thrombosis (OR 3.2, CI 1.2–8.2, p=0.019). The presence of malignancy was a relevant risk factor for long-term mortality (OR 4.3, CI 1.8–10.3, p=0.001).ConclusionSurgical pulmonary embolectomy as a therapy for acute pulmonary embolism demonstrates excellent short- and long-term results in patients with an otherwise life-threatening disease, especially in younger patients with a body surface area >2 m2 and pulmonary embolism caused by deep vein thrombosis. Pulmonary embolectomy should therefore not be reserved as a treatment of last resort for clinically desperate circumstances.

Download Full-text

Adverse events in hip and knee surgeries: post-operative pulmonary embolism (PE) or deep vein thrombosis (DVT), 2017 (or nearest year)

Health at a Glance - Health at a Glance 2019 ◽

10.1787/647534d1-en ◽

2019 ◽

Keyword(s):

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Adverse Events ◽

Vein Thrombosis ◽

Deep Vein

Download Full-text

Mechano-Rheological Properties of the Murine Thrombus Determined via Nanoindentation and Finite Element Modeling

ASME 2009 Summer Bioengineering Conference, Parts A and B ◽

10.1115/sbc2009-206520 ◽

2009 ◽

Author(s):

Constance L. Slaboch ◽

Timothy C. Ovaert

Keyword(s):

Mechanical Properties ◽

Pulmonary Embolism ◽

Abdominal Aortic Aneurysm ◽

Deep Vein Thrombosis ◽

Blood Clot ◽

Flow Conditions ◽

Vein Thrombosis ◽

Abdominal Aortic ◽

Life Threatening ◽

Deep Vein

Deep vein thrombosis (DVT) is the formation of a thrombus, or blood clot, in one of the extremities, often in the vein of a leg. Approximately 2 million incidences of DVT occur annually [1]. Roughly 300,000 people die due to the development of a pulmonary embolism (PE), which occurs when the thrombus from a DVT relocates to the pulmonary artery. Abdominal aortic aneurysm (AAA) is another life-threatening disease involving thrombi, resulting in 15,000 deaths annually. Increased life expectancy raises significant concern for AAA, as it generally affects people age 55 and older. Together, these diseases impinge over 2.5 million people each year. Determining the mechanical properties of thrombi, which can be platelet- and/or fiber-rich, and understanding how they dissociate or fail mechanically under fluid flow conditions, can help diagnose these diseases at an earlier stage in their progression, thereby providing time to initiate treatments. In addition, increased knowledge of thrombi properties can lead to the development of preventative drug therapies. Both of these outcomes have the potential to decrease the number of deaths from the aforementioned diseases.

Download Full-text

Predicting Adverse Outcome in Patients with Acute Pulmonary Embolism: A Risk Score

Thrombosis and Haemostasis ◽

10.1055/s-0037-1614065 ◽

2000 ◽

Vol 84 (10) ◽

pp. 548-552 ◽

Cited By ~ 230

Author(s):

Jacques Wicki ◽

Thomas Perneger ◽

Henri Bounameaux ◽

Alain Junod ◽

Arnaud Perrier

Keyword(s):

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Adverse Events ◽

Risk Score ◽

Major Bleeding ◽

Acute Pulmonary Embolism ◽

Adverse Outcome ◽

Vein Thrombosis ◽

Risk Patients ◽

Deep Vein

SummaryReliable prediction of adverse outcomes in acute pulmonary embolism may help choose between in-hospital and ambulatory treatment. We aimed to identify predictors of adverse events in patients with pulmonary embolism and to generate a simple risk score for use in clinical settings. We prospectively followed 296 consecutive patients with pulmonary embolism admitted through the emergency ward. Logistic regression was used to predict death, recurrent thromboembolic event, or major bleeding at 3 months. Thirty patients (10.1%) had one or more adverse events during the 3-month follow-up period: 25 patients (8.4%) died, thromboembolic events recurred in 10 patients (3.4%), and major bleeding occurred in 5 patients (1.7%). Factors associated with an adverse outcome in multivariate analysis were cancer, heart failure, previous deep vein thrombosis, systolic blood pressure <100 mmHg, arterial PaO2 <8 kPa, and presence of deep vein thrombosis on ultrasound. A risk score was calculated by adding 2 points for cancer and hypotension, and 1 point each for the other predictors. A score of 2 best identified patients at risk of an adverse outcome in a receiver operating characteristic curve analysis. Of 180 low-risk patients (67.2%) (score ≤2), only 4 experienced an adverse outcome (2.2%), compared to 23 (26.1%) of 88 high-risk patients (score ≥3). A simple risk score based on easily available variables can accurately identify patients with pulmonary embolism at low risk of an adverse outcome. Such a score may be useful for selecting patients with pulmonary embolism eligible for outpatient care.

Download Full-text